Related Experiment Video
Updated: Jul 26, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Meconium-Stained Amniotic Fluid: Impact on Prognosis of Neonatal Bacterial Meningitis
Ya-Ting Li1, Cai-Xia Li1, Chu-Jun Huang2
1Department of Pediatrics, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Objectives:
Clinical data with respect to the impact of meconium on the prognosis of neonatal bacterial meningitis are scarce. Therefore, in this study, we aimed to determine whether meconium-stained amniotic fluid (MSAF) represents a risk factor for poor prognosis of neonatal bacterial meningitis in a confirmed case population.
Methods:
This was a retrospective cohort study of 256 neonates diagnosed with bacterial meningitis hospitalized at one of three hospitals in Shantou, China, between October 2013 and September 2018. Clinical manifestation, laboratory test results and treatment were compared between the two groups, with outcomes dichotomized into 'good' or 'poor' prognosis. Multivariate analysis and follow-up logistic regression analysis were used to identify predictive factors of a poor outcome.
Results:
Of the 256 neonates with BM, 95 (37.1%) had a good prognosis at discharge and 161 (62.9%) had a poor prognosis. In the poor prognosis group, 131/161 (79.4%) neonates had a permanent neurological sequelae and 19 (11.8%) had ≥2 sequelae. Of note, 11 neonates died. The rate of poor prognosis of BM was significantly higher among neonates with than without MSAF (26.1% vs. 12.6%, respectively; p < 0.05). A logistic multivariate analysis to evaluate the prognostic effect of MSAF to BM showed that neonatal with MSAF is more likely to have a worse prognosis of BM [unadjusted odds ratio (OR), 2.44, 95% confidence interval (CI), 1.24-5.10; adjusted OR, 2.31; 95% CI, 1.09-5.17].
Conclusion:
MSAF is significantly associated with poor prognosis of neonatal bacterial meningitis. Therefore, in case of MSAF, more attention should be paid to neonatal bacterial meningitis.
Insights
Meconium-stained amniotic fluid (MSAF) significantly increases the risk of poor outcomes in neonatal bacterial meningitis (BM). This finding highlights the need for increased vigilance for BM in infants exposed to MSAF.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Pediatric Neurology
Background:
- Neonatal bacterial meningitis (BM) poses a significant threat to infant health.
- Limited data exists on the impact of meconium exposure on BM prognosis.
- Meconium-stained amniotic fluid (MSAF) is a potential risk factor requiring investigation.
Purpose of the Study:
- To investigate the association between MSAF and the prognosis of neonatal bacterial meningitis.
- To identify MSAF as a potential risk factor for adverse outcomes in neonatal BM.
Main Methods:
- Retrospective cohort study of 256 neonates with BM.
- Comparison of clinical data, laboratory results, and treatment between neonates with and without MSAF.
- Multivariate logistic regression analysis to determine prognostic factors.
Main Results:
- A higher rate of poor prognosis was observed in neonates with MSAF (26.1%) compared to those without (12.6%).
- MSAF was independently associated with a worse prognosis for neonatal BM (adjusted OR, 2.31).
- Poor prognosis included permanent neurological sequelae and mortality.
Conclusions:
- MSAF is a significant risk factor associated with poor prognosis in neonatal bacterial meningitis.
- Increased clinical attention is warranted for neonates with MSAF presenting with or suspected of having BM.
- Early identification and management of BM in MSAF-exposed infants may improve outcomes.
Related Concept Videos
Development of the Oral Microbiota
Bacterial Meningitis
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

